Donna Hallas discusses the Pfizer-BioNTech vaccine booster for children 5 to 11 years old

Article

Contemporary Pediatrics® Editorial Advisory Board member Donna Hallas shares her thoughts on the recent authorization of a Pfizer-BioNTech COVID-19 booster shot for children 5-11 years old.

In a video for Contemporary Pediatrics®, Donna Hallas, PhD, CPNP, PPCNP-BC, PMHS, FAANP, FAAN, discussed the recent FDA amendment of the current emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 vaccine which is now authorizing a single booster dose for children 5-11 years old. The Booster will be available to children of this age at least 5 months after completing the primary vaccine series.

Related Videos
Juanita Mora, MD
Importance of maternal influenza vaccination recommendations
Samantha Olson, MPH
Rupa Wong, MD | Image Credit: Rupa Wong, MD
Tina Tan, MD, FAAP, FIDSA, FPIDS, editor in chief, Contemporary Pediatrics, professor of pediatrics, Feinberg School of Medicine, Northwestern University, pediatric infectious diseases attending, Ann & Robert H. Lurie Children's Hospital of Chicago
John Bradley, MD
Related Content
© 2024 MJH Life Sciences

All rights reserved.